BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37197403)

  • 61. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acromegaly without acral changes: A rare presentation.
    Sengupta N; Sinha U; Roy KS; Saha S
    Indian J Endocrinol Metab; 2012 May; 16(3):457-9. PubMed ID: 22629521
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid.
    Drange MR; Melmed S
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3104-9. PubMed ID: 9745411
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acromegaly with normal basal growth hormone levels.
    Mohr G; Chen ZP; Schweitzer M
    Can J Neurol Sci; 1997 Aug; 24(3):250-3. PubMed ID: 9276113
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literature.
    Krug S; Boch M; Rexin P; Pfestroff A; Gress T; Michl P; Rinke A
    BMC Res Notes; 2016 Jun; 9():326. PubMed ID: 27349224
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 67. EMPTY SELLA IN A PATIENT WITH CLINICAL AND BIOCHEMICAL DIAGNOSIS OF ACROMEGALY.
    Bestepe N; Aydin C; Tam AA; Ercan K; Ersoy R; Cakir B
    Acta Endocrinol (Buchar); 2022; 18(1):97-101. PubMed ID: 35975262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Familial acromegaly: a familial report and review of the literature.
    Tiryakioğlu O; Caneroğlu NU; Yilmaz E; Gazioğlu N; Kadioğlu P; Açbay O; Gündoğdu S
    Endocr Res; 2004 May; 30(2):239-45. PubMed ID: 15473133
    [TBL] [Abstract][Full Text] [Related]  

  • 69. REDUCTION IN THYMOMA SIZE AFTER PITUITARY SURGERY FOR GROWTH HORMONE-SECRETING TUMOR.
    Padmanabhan H
    AACE Clin Case Rep; 2019; 5(2):e164-e167. PubMed ID: 31967025
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion.
    Moller DE; Moses AC; Jones K; Thorner MO; Vance ML
    J Clin Endocrinol Metab; 1989 Feb; 68(2):499-504. PubMed ID: 2493033
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ockham's Razor for a Retinal Lesion and Acromegaly and Breaking the Vicious Circle.
    Rak-Makowska B; Khoo B; Sen Gupta P; Plowman PN; Grossman AB; Korbonits M
    J Endocr Soc; 2022 Jul; 6(7):bvac083. PubMed ID: 35702603
    [TBL] [Abstract][Full Text] [Related]  

  • 72. First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial.
    Colao A; Pivonello R; Rosato F; Tita P; De Menis E; Barreca A; Ferrara R; Mainini F; Arosio M; Lombardi G
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):342-51. PubMed ID: 16487447
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Case of Acromegaly Caused by Rathke Cleft Cyst Mimicking Plurihormonal Pituitary Adenoma.
    Morinaga Y; Nii K; Sakamoto K; Inoue R; Mitsutake T; Hanada H
    World Neurosurg; 2019 Jun; 126():570-575. PubMed ID: 30862574
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I.
    Yamasaki R; Saito H; Sano T; Kameyama K; Yoshimoto K; Hosoi E; Matsumura M; Harada K; Saito S
    Endocrinol Jpn; 1988 Feb; 35(1):97-109. PubMed ID: 2899505
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Resolution of acromegaly after removal of a bronchial carcinoid shown to secrete growth hormone releasing factor.
    Carroll DG; Delahunt JW; Teague CA; Cooke RR; Adams EF; Christofides ND; Bloom SR; Terenghi G; Polak JM
    Aust N Z J Med; 1987 Feb; 17(1):63-7. PubMed ID: 3113410
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Delayed diagnosis of acromegaly in a patient with focal segmental Glomerulosclerosis: a rare case report and literature review.
    Zheng J; Cui Z; Lv JC; Duan HZ; Wang SX; Zhang JQ; Zhou FD; Guo XH; Zhao MH
    BMC Nephrol; 2019 Nov; 20(1):435. PubMed ID: 31771524
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
    Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
    J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR.
    Jenkins PJ; Emery M; Howling SJ; Evanson J; Besser GM; Monson JP
    Horm Res; 2004; 62(5):227-32. PubMed ID: 15477693
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ectopic secretion of GHRH by a pancreatic neuroendocrine tumor associated with an empty sella.
    Mnif Feki M; Mnif F; Kamoun M; Charfi N; Rekik N; Naceur BB; Mnif L; Boudawara TS; Abid M
    Ann Endocrinol (Paris); 2011 Dec; 72(6):522-5. PubMed ID: 21963237
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Acromegaly].
    Chanson P
    Presse Med; 2009 Jan; 38(1):92-102. PubMed ID: 19004612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.